Commissioning a new pharmaceutical production line

Commissioning a new pharmaceutical production line is the qualified, documented process of proving that newly installed process equipment performs reliably and reproducibly before it makes product. It follows the qualification ladder — installation, operation and performance qualification — under change control, so the line is verified fit for regulated manufacture.

1Installationchecks2Calibration3Operational test4Performance runs5Deviationclose-out6Documentedhandover
Commissioning a new pharmaceutical production line — typical sequence

What it is

A pharma line is not 'switched on'; it is qualified. Commissioning and qualification (C&Q) is the structured evidence trail that each piece of equipment was installed to specification, operates across its full range, and performs consistently when running representative material. The deliverable is a documented, traceable package, not just a working machine.

Why it is done

In regulated manufacture, an unqualified line cannot release product. Beyond compliance, structured C&Q catches design and integration faults while they are cheap to fix, establishes the operating parameters later validated for the process, and prevents the costly investigations that follow when a line behaves unpredictably in production.

How it is done

Commissioning begins with installation checks — utilities, calibration, materials of construction and as-built drawings verified against the design. Operational testing then exercises every function, alarm and interlock across the design range, often with water or placebo. Performance testing runs the equipment under representative process conditions to show reproducibility. Throughout, deviations are logged and closed under change control, and the qualification documents are reviewed and approved before handover.

  1. Installation checks
  2. Calibration
  3. Operational test
  4. Performance runs
  5. Deviation close-out
  6. Documented handover

What to watch for

Risk concentrates where commissioning and qualification overlap: repeating tests needlessly inflates cost, while gaps between them leave functions unproven. Poor calibration traceability and weak as-built documentation are the faults most often found later in audits.

Related practices

Related topics

All industrial practices →